基于ICT为患有MCI和痴呆症的老年人提供认知支持的有效性,采用决定因素和实施挑战:符合PRISMA的系统审查和元分析 (2015-2025)
Ashrafe Alam1, Md Golam Rabbani1, Victor R Prybutok2
1Department of Information Science, University of North Texas, Denton, TX 76207, USA.
Healthcare (Basel, Switzerland)
|June 26, 2025
概括
信息和通信技术 (ICT) 干预措施有效地支持轻度认知障碍 (MCI) 和痴呆症的老年人的认知. 成功实施的关键因素包括以用户为中心的设计和护理人员对可扩展性的支持.
科学领域:
- 老年学是指老年学的学科.
- 数字健康数字健康
- 认知科学 认知科学
背景情况:
- 痴呆症和轻度认知障碍 (MCI) 的全球增长需要创新的干预措施.
- 信息和通信技术 (ICT) 为老年人的认知维护提供了潜在的潜力.
- 采用ICT的挑战包括数字素养,可用性和隐私问题.
研究的目的:
- 评估基于ICT的认知和记忆辅助技术对MCI或痴呆症患者的有效性.
- 确定采用这些技术的关键驱动因素.
- 在临床实践中开发ICT干预措施的实施模型.
主要方法:
- 在七个电子数据库 (2015年1月至2025年1月) 进行了基于PRISMA的系统文献审查.
- PECOS框架指导了研究选择,并使用随机效应模型进行元分析.
- 使用Joanna Briggs Institute (JBI) 批判性评估检查清单来评估偏差风险.
主要成果:
- 确定了十种有效的ICT干预措施,以支持患有MCI和痴呆症的老年人.
- 信息和通信技术的干预显示了认知结果的适度改善 (合并的科恩d=0.49).
- 障碍包括数字素养和可用性;促进者是个性化设计和护理人员参与.
结论:
- 基于ICT的干预措施显著提高了MCI和痴呆症的老年人的认知能力,自主性和社交互动.
- 成功的长期实施需要以用户为中心的设计,护理人员教育和公平的技术访问.
- 支持性政策框架和可访问的基础设施对于可扩展性至关重要.
关键词:
信息和通信技术 (ICT) 是一种信息技术.辅助技术是指辅助技术的使用.认知支持是认知支持.痴呆症 痴呆症是一种痴呆症.数字健康数字健康数字素养数字素养医疗保健技术 医疗保健技术 医疗保健技术轻度的认知障碍 轻度的认知障碍技术采用 技术采用更多相关视频
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.0K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.8K
相关概念视频
01:30Cognitive Development During Adulthood
303
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
303
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214